Anteotech (ASX: ADO) — Perfil da empresa, notícias e dados financeiros
Anteotech is a surface chemistry and nanotechnology company that develops novel materials for the life sciences and clean energy sectors.
Anteotech
Anteotech is a surface chemistry and nanotechnology company that develops novel materials for the life sciences and clean energy sectors. The company creates proprietary surface management technologies used in in-vitro diagnostics, medical devices, and point-of-care test development across healthcare, agriculture, and veterinary fields. Additionally, it develops advanced battery technologies, including cross-linking binder additives and high-silicon anode solutions designed to enhance energy density, charging efficiency, and stability in lithium-ion batteries. Anteotech collaborates with global manufacturing and distribution partners to commercialize its chemical additives, diagnostic kits, and battery material innovations.
Resumo
Operações
Produtos e/ou serviços de Anteotech
- Battery Additives: Manufacturing and commercializing cross-linking polymer binder additives that improve electrode cohesion, silicon capacity retention, and electrochemical stability in high-silicon lithium-ion battery anodes for electric vehicle and consumer electronics applications.
- Silicon Anode Technology: Developing high-content silicon anode active materials engineered to increase energy density and battery storage capacity, enabling lighter and more compact battery packs for integration into commercial clean energy supply chains.
- Diagnostic Reagents: Formulating surface-modifying nanoparticle synthetic binding reagents used in immunoassay development, enhancing biomolecule conjugation efficiency and assay sensitivity for diagnostic testing across human healthcare, agricultural, and veterinary science sectors.
- Point-of-Care Diagnostics: Designing and manufacturing rapid point-of-care diagnostic test kits, fluorescent reader devices, and assay systems that enable rapid pathogen detection and biomarker monitoring across clinical, veterinary, and field-based healthcare settings.
- Assay Development Services: Providing custom contract research, biomolecule conjugation, and assay development services, enabling third-party diagnostic manufacturers and biotechnology companies to optimize nanoparticle surface binding, assay stability, and commercial kit performance.
- International Distribution Partnerships: Collaborating with international scientific distribution partners and chemical suppliers to deliver specialized surface chemistry reagents, diagnostic raw materials, and advanced battery additives to commercial customers across Asia, Europe, and North America.
equipe executiva do Anteotech
- Merrill Christina GrayMD, CEO & Director
- Manuel WieserChief Technology Officer
- Selahattin GulduExecutive Vice President of Commercial Banking
- Friederike GraserDirector of Strategic Growth Initiatives
Últimas notícias sobre a Anteotech
Comunicados recentes
O que a Anteotech (ADO) comunicou ao mercado, do mais recente para o mais antigo.
- Notice of Annual General Meeting/Proxy Form
Principais indicadores financeiros
Resultados divulgados pela Anteotech.
- Cap. de mercado
- 52,2 mi
- Receita (TTM)
- 467,6 mil
- P/L
- —
- LPA (diluído, TTM)
- 0.0
- Dividend yield
- —
- Margem de lucro
- 0.0%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 467,6 mil | -7,9 mi | -5,4 mi | |
| 968,9 mil | -8,1 mi | -6,8 mi | |
| 460,4 mil | -12,8 mi | -8,9 mi | |
| 365,7 mil | -13,4 mi | -12,7 mi |